期刊文献+

葡萄糖依赖性促胰岛素多肽与多囊卵巢综合征相关性的研究进展

Advances in the study of the correlation between incretin hormone GIP and polycystic ovary syndrome
下载PDF
导出
摘要 多囊卵巢综合征(PCOS)是育龄妇女常见的生殖和内分泌疾病之一,机制未明,但胰岛素抵抗、高雄激素血症、肥胖是其重要的病理生理基础。葡萄糖依赖性促胰岛素多肽(GIP)是一种参与调控胰岛素分泌的胃肠激素,与胰岛素抵抗、高雄激素血症、肥胖等PCOS的特征性改变具有相关性,可能通过影响下丘脑-垂体-卵巢轴的功能促进PCOS的发生与发展,提示GIP与PCOS相关。就GIP与PCOS相关性的研究现状进行综述。 Polycystic ovary syndrome(PCOS)is one of the most common reproductive and endocrine disorders in women of childbearing age,and the pathogenesis is unknown.Insulin resistance,hyperandrogenism and obesity are important pathophysiological basis.Glucose-dependent insulinotropic peptide(GIP)is a gastrointestinal hormone involved in the regulation of insulin secretion.Literature studies have shown that GIP is correlated with insulin resistance,hyperandrogenism,obesity and other characteristic changes of PCOS,and it may contribute to the onset and progression of PCOS by affecting the function of hypothalamic-pituitary-ovarian axis,suggesting that GIP is associated with PCOS.This paper reviews the research progress of the correlation between GIP and PCOS.
作者 范哲华 刘建荣 FAN Zhehua;LIU Jianrong(The Fifth Clinical Medical College of Shanxi Medical University,Taiyuan 030000,China;Reproductive Medical Center,Shanxi Provincial People’s Hospital)
出处 《天津医药》 CAS 2024年第9期996-1000,共5页 Tianjin Medical Journal
基金 国家自然科学基金资助项目(81973864) 中央引导地方科技发展资金项目(YDZJSX2022A069)。
关键词 多囊卵巢综合征 肥胖症 胰岛素抵抗 葡萄糖依赖性促胰岛素多肽 高雄激素血症 下丘脑-垂体-卵巢轴 polycystic ovary syndrome obesity insulin resistance glucose-dependent insulinotropic polypeptide hyperandrogenism hypothalamic-pituitary-ovarian axis Tianjin Med J,September 2024,Vol.52 No.9
  • 相关文献

参考文献5

二级参考文献29

  • 1陈子江,赵君利,周凤荣,李媛,赵力新,马增香.济南市汉族育龄妇女PCOS患病状况的初步调查[J].现代妇产科进展,2005,14(6):442-444. 被引量:41
  • 2赵君利,陈子江,赵力新,耿玲,王珊,高姗姗,张鹏,刘姗,周凤荣.汉族育龄多囊卵巢综合征患者的临床特征及分析[J].中华妇产科杂志,2006,41(6):375-379. 被引量:20
  • 3Diamanti-Kandarakis E, Christakou C, In Farid NR, et al. Diagnosis and Management of polycystic ovary syndrome [M]. Springer, 2009: 35-52.
  • 4Elrick H, Stimmler L, Hlad CJ Jr, et al. Plasma insulin re- sponse to oral and intravenous glucose administration [ J ]. J Clin Endocrinol Metab, 1964, 24: 1076-1082.
  • 5Krarup T. Immunoreactive gastric inhibitory polypeptide [ J ]. EndocrRev, 1988, 9: 122-134.
  • 6Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP [J]. Gastroenterology, 2007, 132 (6): 2131-2157.
  • 7Elkind-Hirsch K, Marrioneaux O, Bhushan M, et al. Com- parison of single and combined treatment with exenatide and metformin on menstrual cyclicity in overweight women with polycystic ovary syndrome [ J]. J Clin Endocrinol Metab, 2011, 93 (7) : 2670-2675.
  • 8Vrbikova J, Hill M, Bendlova B, et al. Incretin levels in poly cystic ovary syndrome [J]. Eur J Endocrinol, 2008, 159 (2) : 121-127.
  • 9MusceUi E, Camastra S, Tesi F, et al. Separate impact of obe- sity and glucose tolerance on incretin effect in humans [ J]. Diabetologia, 2008, 57 (5): 1340-1348.
  • 10Pontikis C, Yavropoulou MP, Toulis KA, et al. The incretin effect and secretion in obese and lean women with polycystic o- vary syndrome: a pilot study [J]. J Womens Health (Larch- mr), 2011, 20 (6): 971-976.

共引文献214

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部